The tumor in the eyes of the surgeon.
As a surgeon, the tumor is one of the most important and challenging rivals of my career. In the field of medicine, our struggle with tumours has never stopped, and every operation is a life-related battle.
Tumours, in short, are the organisms that, as a result of a variety of tumour causes, local tissue cells lose normal regulation of their growth at the genetic level, resulting in an abnormal increase in cloning and the creation of new organisms. It may sound a little obscure, but it’s the key to understanding the nature of the tumor. The tumours are benign and vicious, and the difference is like a gentle sheep and a fierce wolf.
Good tumours usually have clear boundaries, like fences. They grow at a relatively slow pace and do not grow like malignant tumours. Moreover, the forms and functions of benign tumour cells are similar to those of normal tissue cells, and the oppression of surrounding tissues is often their main hazard. For example, the fatomas that are long on the surface often touch a corrosive mass with clear borders, which generally does not encroach on the muscles, veins and nerves around them, with few re-emergences as a result of a complete surgical removal and a lower risk to the life and health of the patient. In this case, our surgeon’s task is to detach the tumor from the body, like the removal of a non-threat-free bomb, while minimizing damage to the normal organization around it and allowing the patient to recover quickly.
Malignant tumours, however, are simply another terrible presence. It is like a cunning and vicious enemy, with great destructive power. Malignant neoplasm cells have the capacity for infinity, and they are not subject to normal body control mechanisms and are rapidly divided and growing. The form and functions of these cells are very different from those of normal cells, and they are capable of distilling special substances, destroying the surrounding tissue environment and opening the way for their own growth. Worse still, malignant neoplasm cells are intrusive and, like roots, they spread to the surrounding tissues, organs and erode vital structures, such as blood vessels and nerves. For example, in the case of stomach cancer, cancer cells may break through the stomach wall and violate the surrounding organs of pancreas, liver, etc., resulting in impaired functioning of these organs.
Moreover, malignant tumours have the ability to transfer. This is its deadliest “weapons”. Carcinocellular cells can reach other parts of the body through blood circulation or lymphocyte systems, where they form roots and form new oncology stoves. It’s like the seed of a plume, blown all over the place and took root. Once transferred, the difficulty of treatment increases geometrically. In the case of surgeons, it is far from sufficient to remove the tumour from the tumour, which is likely to recur if the transferred cancer cells are not completely removed. This requires us to conduct a thorough examination before the operation, to determine as accurately as possible whether the tumor has been transferred and where it has been transferred.
In the case of tumour patients, we surgeons make complex and careful decisions. In the case of early tumours, in particular malignant tumours that have not yet been transferred, surgical removal is often the preferred treatment. This requires us to have excellent surgical skills and anatomy. On the operating table, every knife is about the patient ‘ s life and death. We need to keep the physiology of the patient to the maximum extent while removing the tumor. For example, in the removal of thyroid cancer, care is taken to protect the larynx back to the nerve and the thyroid prostate, otherwise the patient may have serious complications such as acoustic and calcium convulsions after the surgery.
In many cases, however, simple surgery cannot completely defeat the tumor. In the case of patients with malignant neoplasms in the middle and late stages, the operation may be only part of a comprehensive treatment. New pre-operative assisted chemotherapy can reduce the size of the tumour, reduce the difficulty of the surgery and increase the cision rate; post-operative assisted chemotherapy or release can kill possible remaining cancer cells and reduce the risk of relapse. In addition, as medical technology continues to develop, new treatments such as target-oriented treatment and immunotherapy are gradually being applied to the treatment of tumours, which can more precisely attack cancer cells while reducing damage to normal cells.
Communication with patients and their families is also essential in the treatment of tumours. We would like to explain to them the nature of the tumor, the treatment, the possible risks and the prognosis, so that they are well informed and psychologically prepared to face this terrible enemy. At the same time, we must give them hope and confidence and encourage them to cooperate actively in the treatment.
Tumours are a major threat to human health, but, as surgeons, we are at the forefront of the fight against tumors. Every successful operation, every patient’s recovery, is the driving force behind us. We continue to learn new knowledge and technology in the hope that we will bring hope to more oncologists and that they will regain their health in this battle against the disease.
